Related Experiment Video
Updated: Sep 4, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Growth in individuals with SATB2-associated syndrome
Yuri A Zarate1, Amrit Kannan2, Katherine A Bosanko1
1Section of Genetics and Metabolism, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Insights
SATB2-associated syndrome (SAS) causes growth issues. New SAS-specific growth charts reveal slower postnatal growth and lower BMI in affected children compared to general populations.
Area of Science:
- Genetics
- Pediatrics
- Human Growth and Development
Background:
- SATB2-associated syndrome (SAS) is a genetic disorder impacting development.
- Individuals with SAS often experience persistent feeding difficulties and growth retardation.
Purpose of the Study:
- To create SAS-specific growth charts for children aged 0-10 years.
- To analyze growth patterns and identify factors influencing growth in SAS.
Main Methods:
- Collected growth data from 211 individuals with SAS.
- Constructed sex-specific growth charts from birth to 10 years.
- Compared SAS growth percentiles with WHO and CDC normative data.
Main Results:
- SAS-specific growth charts show slower postnatal growth.
- A significant percentage of individuals with SAS had measurements below -2 standard deviations.
- BMI Z-scores were consistently below normative data, especially in those with chromosomal abnormalities.
Conclusions:
- SAS is associated with significant growth deficits.
- Chromosomal abnormalities in SAS correlate with more severe growth impairment.
- SAS-specific growth charts are crucial for monitoring affected individuals.
Abstract:
SATB2-associated syndrome (SAS) is an autosomal dominant multisystemic disorder caused by alterations in the SATB2 gene. In addition to a predominant neurodevelopmental phenotype, individuals with SAS often present with feeding difficulties and growth retardation that persist past infancy. In this study, we present growth and measurement data from 211 individuals (53.6% male, 46.4% female) with SAS due to different molecular mechanisms. To delineate growth in this population, we constructed SAS-specific growth charts by sex from birth to 10 years of age. Smoothed SAS percentiles were superimposed with normative percentiles from WHO (birth to <24 months) and CDC (24 months to 10 years) growth charts. Individuals with SAS tend to display slower postnatal growth with 22.2% (32/144), 19.0% (26/137), and 21.6% having at least one weight, height, or weight-for-length /body mass index (BMI) measurement below -2 standard deviations, respectively. The SAS 50th centile BMI was consistently below the normative data 50th centile and negative mean Z-scores were seen across almost all age groups analyzed for both genders. Individuals with chromosomal abnormalities displayed significantly lower weight for age Z-score, height for age Z-scores, occipitofrontal head circumference for age Z-scores, and BMI for age Z-scores compared to either missense or null variants.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Pleiotropy
Pedigree Analysis
Karyotyping
Social Anxiety Disorder

